Status:
COMPLETED
Analysis of Defocus Curve of Pre-Presbyopic and Emerging Presbyopic Patients
Lead Sponsor:
Vance Thompson Vision
Collaborating Sponsors:
Alcon Research
Conditions:
Presbyopia
Eligibility:
All Genders
37-48 years
Brief Summary
Educating patients on visual performance with presbyopic correcting intraocular lenses is crucial. Understanding the defocus curve of pre-presbyopic and emerging presbyopic crystalline lens will provi...
Eligibility Criteria
Inclusion
- Able and willing to provide written informed consent on the IRB approved Informed Consent Form
- 37-48 years of age
- Phakic
Exclusion
- Previous cataract surgery
- Any pathology for which, in the investigator's judgement, could reduce the subjects BCVA
- Subjects that are unable to obtain 20/20 BCVA (i.e. amblyopia, etc.)
Key Trial Info
Start Date :
October 17 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2020
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04474782
Start Date
October 17 2019
End Date
August 31 2020
Last Update
March 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vance Thompson Vision
Sioux Falls, South Dakota, United States, 57108